Current Enterprise Value (EV)
Current share price (P) | $273.56 |
No. shares of common stock outstanding | 144,001,404 |
US$ in thousands | |
Common equity (market value)1 | 39,393,024) |
Add: Preferred stock, par value $0.001 per share (per books) | —) |
Add: Noncontrolling interests (per books) | 63,500) |
Total equity | 39,456,524) |
Add: Current portion of notes payable (per books) | 999,100) |
Add: Notes payable, excluding current portion (per books) | 6,274,000) |
Total equity and debt | 46,729,624) |
Less: Cash and cash equivalents | 2,261,400) |
Less: Marketable securities | 1,541,100) |
Enterprise value (EV) | 42,927,124) |
Based on: 10-K (reporting date: 2021-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 273.56 × 144,001,404
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Biogen Inc. Annual Report.
3 2021 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 220.17 × 146,962,793
Item | Description | The company |
---|---|---|
EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | Biogen Inc. EV decreased from 2019 to 2020 and from 2020 to 2021. |